keyword
MENU ▼
Read by QxMD icon Read
search

Hormonal contraception side effectS

keyword
https://www.readbyqxmd.com/read/27852187/prevention-of-breast-cancer
#1
Ian N Olver
Modifiable lifestyle factors may reduce the risk of developing breast cancer. Obesity is associated particularly with post-menopausal breast cancer. Diet is important, and exercise equivalent to running for up to 8 hours each week reduces the risk of breast cancer, both in its own right and through reducing obesity. Alcohol consumption may be responsible for 5.8% of breast cancers in Australia and it is recommended to reduce this to two standard drinks per day. Drinking alcohol and smoking increases the risk for breast cancer and, therefore, it is important to quit tobacco smoking...
November 21, 2016: Medical Journal of Australia
https://www.readbyqxmd.com/read/27715345/discontinuation-of-modern-hormonal-contraceptives-an-italian-survey
#2
Franca Fruzzetti, Daria Perini, Lara Fornaciari, Marinella Russo, Fiorella Bucci, Angiolo Gadducci
OBJECTIVES: The aim of the study was to examine, in a sample of Italian women, the rate of discontinuation of use of hormonal contraception. METHODS: In a retrospective cross-sectional study, data were collected from a chart review of 1809 women using or stopping the hormonal contraceptive prescribed by their physician. The name of the contraceptive and the reason for discontinuation were taken from the charts. The differences between the methods regarding reasons for discontinuation were analysed...
October 7, 2016: European Journal of Contraception & Reproductive Health Care
https://www.readbyqxmd.com/read/27704541/user-characteristics-experiences-and-continuation-rates-of-copper-intrauterine-device-use-in-a-cohort-of-australian-women
#3
Deborah Bateson, Caroline Harvey, Lieu Trinh, Mary Stewart, Kirsten I Black
BACKGROUND: Copper intrauterine device (Cu-IUD) use in Australia is low despite being a highly effective, cost effective non-hormonal contraceptive with reported 12-month continuation rates of 85% compared to 59% for oral contraception. AIMS: To describe the characteristics of Cu-IUD users in the Australian context, their experiences of side effects, continuation rates and reasons for discontinuation. METHODS: Between August 2009 and January 2012 we undertook a prospective cohort study of consecutive women presenting for Cu-IUD insertion to three family planning clinics in Queensland and New South Wales...
December 2016: Australian & New Zealand Journal of Obstetrics & Gynaecology
https://www.readbyqxmd.com/read/27671673/extended-use-up-to-5-years-of-the-etonogestrel-releasing-subdermal-contraceptive-implant-comparison-to-levonorgestrel-releasing-subdermal-implant
#4
Moazzam Ali, Ayse Akin, Luis Bahamondes, Vivian Brache, Ndema Habib, Sihem Landoulsi, David Hubacher
STUDY QUESTION: Is it possible to extend the use of the 3-year one-rod etonogestrel (ENG)-releasing subdermal contraceptive implant to 5 years? SUMMARY ANSWER: The extended use of the one-rod ENG-releasing subdermal contraceptive implant showed 100% efficacy in years 4 and 5. WHAT IS KNOWN ALREADY: The initial regulated trials on the ENG-releasing subdermal contraceptive implant conducted in the 1990 s were designed to measure cumulative 3-year efficacy...
November 2016: Human Reproduction
https://www.readbyqxmd.com/read/27636867/combined-hormonal-contraception-and-its-effects-on-mood-a-critical-review
#5
Jonathan Schaffir, Brett L Worly, Tamar L Gur
OBJECTIVES: Adverse mood changes are sometimes cited as a reason for discontinuing combined hormonal contraception (CHC). A systematic review of recent literature was undertaken to characterise the nature of these side effects and identify characteristics that might predispose women to such effects. METHODS: A MEDLINE review of studies from the past 30 years that focused on CHC and mood was performed. Database search was supplemented with studies found through citations and references...
October 2016: European Journal of Contraception & Reproductive Health Care
https://www.readbyqxmd.com/read/27594105/pharmacist-prescription-of-hormonal-contraception-in-oregon-baseline-knowledge-and-interest-in-provision
#6
Maria I Rodriguez, K John McConnell, Jonas Swartz, Alison B Edelman
OBJECTIVES: Oregon has implemented legislation expanding the scope of pharmacists to directly prescribe short-acting hormonal contraception (pill and patch) without a medical prescription. Pharmacists are crucial to the success of the new law, but relatively little is known about their intentions to prescribe contraception, or the motivators or barriers in providing this service. METHODS: With the use of a cross-sectional survey of pharmacists practicing in Oregon before the legislative implementation, we analyzed responses to assess contraceptive knowledge, motivation to participate in direct provision, and perception of barriers to pharmacist prescription of contraception...
September 2016: Journal of the American Pharmacists Association: JAPhA
https://www.readbyqxmd.com/read/27538740/the-changing-pattern-of-contraceptive-use-and-pregnancies-in-four-generations-of-young-women
#7
Ingela Lindh, Helena Hognert, Ian Milsom
INTRODUCTION: To describe contraceptive use and pregnancies and their relationship to socio-economic status (SES) in four generations of young Swedish women. MATERIAL AND METHODS: Questionnaires regarding contraceptive use and pregnancies and were sent to random samples of 19-year old women in 1981, 1991, 2001 and 2011 (n = 4732). RESULTS: Current contraceptive use was higher in 2001 (78%) (p<0.01) and 2011 (69%) (p<0.05) compared to 1981 (60%) and 1991 (62%)...
August 19, 2016: Acta Obstetricia et Gynecologica Scandinavica
https://www.readbyqxmd.com/read/27537097/hormonal-contraceptives-for-contraception-in-overweight-or-obese-women
#8
REVIEW
Laureen M Lopez, Alissa Bernholc, Mario Chen, Thomas W Grey, Conrad Otterness, Carolyn Westhoff, Alison Edelman, Frans M Helmerhorst
BACKGROUND: Obesity has reached epidemic proportions around the world. Effectiveness of hormonal contraceptives may be related to metabolic changes in obesity or to greater body mass or body fat. Hormonal contraceptives include oral contraceptives (OCs), injectables, implants, hormonal intrauterine contraception (IUC), the transdermal patch, and the vaginal ring. Given the prevalence of overweight and obesity, the public health impact of any effect on contraceptive efficacy could be substantial...
2016: Cochrane Database of Systematic Reviews
https://www.readbyqxmd.com/read/27467032/-pharmacokinetic-and-pharmacodynamic-effects-of-psychotropic-medications-differences-between-sexes
#9
J D Bergiannaki, P Kostaras
The gender based or gender sensitive pharmacology is a new research area. Differences among sexes are observed in several parameters of their pharmacokinetic which may relate to alteration of their pharmacodynamic as well. Most psychotropics are given per os, and the greater part of their absorption takes place in the small intestine. Premenopausal women have slower gastric emptying times and lower gastrointestinal blood flow which probably reduces the extent of drug absorption. The distribution of drugs is influenced by the relative lower body mass index, the lower blood volume and flow and the greater percentage of body fat of women...
April 2016: Psychiatrikē, Psychiatriki
https://www.readbyqxmd.com/read/27416311/the-use-of-hormonal-agents-in-the-treatment-of-acne
#10
Lauren A Hassoun, Dev S Chahal, Raja K Sivamani, Larissa N Larsen
Hormones and androgens play an important role in the pathogenesis of acne. Multiple hormonal modulators are now available for the treatment of acne. The efficacies and side effects of currently available hormonal agents are reviewed here including the use of oral contraceptives, spironolactone, flutamide, cyproterone acetate, finasteride, and cortexolone 17α-propionate. Hormonal therapies are an efficacious treatment option for acne among females. With the growing need to reduce antibiotic exposures, hormonal therapies should be more widely studied and incorporated into acne treatment strategies...
June 2016: Seminars in Cutaneous Medicine and Surgery
https://www.readbyqxmd.com/read/27339142/the-other-side-of-progestins-effects-in-the-brain
#11
REVIEW
Silvia Giatti, Roberto Cosimo Melcangi, Marzia Pesaresi
Progestins are a broad class of progestational agents widely differing in their chemical structures and pharmacological properties. Despite emerging data suggest that progestins, besides their action as endometrial protection, can also have multiple nonreproductive functions, much remains to be discovered regarding the actions exerted by these molecules in the nervous system. Here, we report the role exerted by different progestins, currently used for contraception or in postmenopausal hormone replacement therapies, in regulating cognitive functions as well as social behavior and mood...
August 2016: Journal of Molecular Endocrinology
https://www.readbyqxmd.com/read/27337853/reasons-for-intrauterine-device-use-discontinuation-and-non-use-in-malawi-a-qualitative-study-of-women-and-their-partners
#12
RANDOMIZED CONTROLLED TRIAL
Amy G Bryant, Gloria Hamela, Ann Gotter, Gretchen S Stuart, Gift Kamanga
The copper intrauterine device (IUD) is a safe, long-acting, and effective method of contraception that is under-utilized in many countries, including Malawi. A unique cohort of women who had enrolled in a trial of postpartum IUD use one year earlier gave insights into reasons for using, discontinuing, or not using the IUD. We conducted in-depth interviews with 18 women one year after they participated in a pilot study of a randomized controlled trial of postpartum IUD insertion, and 10 of their male partners...
December 2015: African Journal of Reproductive Health
https://www.readbyqxmd.com/read/27328486/hemostatic-effects-of-two-desogestrel-containing-combined-oral-contraceptive-regimens-a-multinational-multicenter-randomized-open-label-study
#13
RANDOMIZED CONTROLLED TRIAL
K Peters, N Gordon, N Ricciotti, J Hsieh, B Howard, H Weiss
PURPOSE OF INVESTIGATION: To compare the effects of desogestrel (DSG) 150 mcg/ethinyl estradiol (EE) 20 mcg for 21 days followed by either seven days of EE ten mcg (21/7-active) or no treatment (DSG/EE+no Tx) on hemostatic markers. MATERIALS AND METHODS: This was a randomized, multicenter, open-label study that enrolled healthy premenopausal women. Non-inferiority of 21/7-active to DSG/EE+no Tx was determined if the upper limit of the two-sided 95% CI of the mean treatment difference in prothrombin fragment 1+2 (F1+2) over 24 weeks between groups was < 130 pmol/L...
2016: Clinical and Experimental Obstetrics & Gynecology
https://www.readbyqxmd.com/read/27311169/-myths-and-realities-of-the-long-term-reversible-contraceptives
#14
REVIEW
José Luis Neyro, Ignacio Cristóbal, Cuauhtémoc Celis-González, Miriam Gómez, Miguel Ángel Elorriaga, Josefina Lira-Plascencia
BACKGROUND: For a woman uses contraception acceptance not only required but also the possibility of minimal or no side effects, comfort and tranquility of their safety. There are women who find it inconvenient not taking the pill daily, but for many other yes, what follows that notwithstanding their safety, do not suit the need of women. IUDs have reached high fees clinical efficacy and safety for use in any group of women, including gilts. METHODOLOGY: A search for original articles and systematic reviews published in the last ten years in the PubMed database, specifically study reversible long-term hormonal contraception was made...
November 2015: Ginecología y Obstetricia de México
https://www.readbyqxmd.com/read/27307386/hormonal-contraceptives-pharmacology-tailored-to-women-s-health
#15
REVIEW
Vincenzo De Leo, Maria Concetta Musacchio, Valentina Cappelli, Paola Piomboni, Giuseppe Morgante
BACKGROUND: In recent years, several new oral contraceptives have become available. In some ways, they represent an evolution in terms of individualization and compliance on the part of women. The new formulations make it increasingly possible to prescribe a specific hormonal contraceptive on an individual basis. METHODS: A systematic literature search of PubMed was performed using the following combination of terms: 'oral contraceptives', 'estroprogestins' and 'combined oral contraceptive'...
September 2016: Human Reproduction Update
https://www.readbyqxmd.com/read/27134949/a-randomised-controlled-trial-comparing-the-efficacy-and-side-effects-of-intravaginal-ring-nuvaring-%C3%A2-with-combined-oral-hormonal-preparation-in-dysfunctional-uterine-bleeding
#16
Sandhya Jain, Neelam B Vaid, Yam Narang, Amita Suneja, Kiran Guleria
INTRODUCTION: Combined Oral Contraceptive (COC) pills are being used in patients of abnormal uterine bleeding, especially adolescents and reproductive age women considering their need for contraception. It decreases the blood loss due to haemostatic effect of estrogen and also regularizes the cycle. Intravaginal route has been found to be effective and acceptable; Gastrointestinal absorption and hepatic first-pass metabolism is avoided and steady, uniform blood concentration is achieved...
March 2016: Journal of Clinical and Diagnostic Research: JCDR
https://www.readbyqxmd.com/read/27126581/gonadotrophin-releasing-hormone-antagonists-for-assisted-reproductive-technology
#17
REVIEW
Hesham G Al-Inany, Mohamed A Youssef, Reuben Olugbenga Ayeleke, Julie Brown, Wai Sun Lam, Frank J Broekmans
BACKGROUND: Gonadotrophin-releasing hormone (GnRH) antagonists can be used to prevent a luteinizing hormone (LH) surge during controlled ovarian hyperstimulation (COH) without the hypo-oestrogenic side-effects, flare-up, or long down-regulation period associated with agonists. The antagonists directly and rapidly inhibit gonadotrophin release within several hours through competitive binding to pituitary GnRH receptors. This property allows their use at any time during the follicular phase...
2016: Cochrane Database of Systematic Reviews
https://www.readbyqxmd.com/read/27106200/canadian-contraception-consensus-part-3-of-4-chapter-8-progestin-only-contraception
#18
Amanda Black, Edith Guilbert, Dustin Costescu, Sheila Dunn, William Fisher, Sari Kives, Melissa Mirosh, Wendy Norman, Helen Pymar, Robert Reid, Geneviève Roy, Hannah Varto, Ashley Waddington, Marie-Soleil Wagner, Anne Marie Whelan
OBJECTIVE: To provide guidelines for health care providers on the use of contraceptive methods to prevent pregnancy and on the promotion of healthy sexuality. OUTCOMES: Overall efficacy of cited contraceptive methods, assessing reduction in pregnancy rate, safety, ease of use, and side effects; the effect of cited contraceptive methods on sexual health and general well-being; and the relative cost and availability of cited contraceptive methods in Canada. EVIDENCE: Published literature was retrieved through searches of Medline and The Cochrane Database from January 1994 to January 2015 using appropriate controlled vocabulary (e...
March 2016: Journal of Obstetrics and Gynaecology Canada: JOGC, Journal D'obstétrique et Gynécologie du Canada: JOGC
https://www.readbyqxmd.com/read/27032746/canadian-contraception-consensus-part-3-of-4-chapter-7-intrauterine-contraception
#19
Amanda Black, Edith Guilbert, Dustin Costescu, Sheila Dunn, William Fisher, Sari Kives, Melissa Mirosh, Wendy Norman, Helen Pymar, Robert Reid, Geneviève Roy, Hannah Varto, Ashley Waddington, Marie-Soleil Wagner, Anne Marie Whelan, Shireen Mansouri
OBJECTIVE: To provide guidelines for health care providers on the use of contraceptive methods to prevent pregnancy and on the promotion of healthy sexuality. OUTCOMES: Overall efficacy of cited contraceptive methods, assessing reduction in pregnancy rate, safety, ease of use, and side effects; the effect of cited contraceptive methods on sexual health and general well-being; and the relative cost and availability of cited contraceptive methods in Canada. EVIDENCE: Published literature was retrieved through searches of Medline and The Cochrane Database from January 1994 to January 2015 using appropriate controlled vocabulary (e...
February 2016: Journal of Obstetrics and Gynaecology Canada: JOGC, Journal D'obstétrique et Gynécologie du Canada: JOGC
https://www.readbyqxmd.com/read/27016468/the-current-state-of-male-hormonal-contraception
#20
REVIEW
Jing H Chao, Stephanie T Page
World population continues to grow at an unprecedented rate, doubling in a mere 50years to surpass the 7-billion milestone in 2011. This steep population growth exerts enormous pressure on the global environment. Despite the availability of numerous contraceptive choices for women, approximately half of all pregnancies are unintended and at least half of those are unwanted. Such statistics suggest that there is still a gap in contraceptive options for couples, particularly effective reversible contraceptives for men, who have few contraceptive choices...
July 2016: Pharmacology & Therapeutics
keyword
keyword
86142
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"